Opportunities and barriers for innovation at the interface of engineering and maternal-fetal medicine

The development of safe and effective maternal-fetal therapeutics is significantly hindered by chronic underfunding, inequitable access to specialized care, and persistent sociopolitical stigmas surrounding women’s health. Addressing these challenges will require interdisciplinary collaboration between clinicians, scientists, and engineers to design accessible therapeutics for maternal-fetal healthcare.